Arrowhead Pharmaceuticals Inc (ARWR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

177 E COLORADO BLVD PASADENA, CA 91105

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechani® to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechani® present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.

Data as of 2021-07-25 16:15:40 -0400
Market Cap7.116 Billion Shares Outstanding104.085 Million Avg 30-day Volume1.183 Million
P/E Ratio-64.93319 Dividend Yield0.0 EPS-1.07
Price/Sales74.08 Debt to Equity1.7 EBITDA-111.274 Million
Price to Book Value14.82 Forward PE9.21 Enterprise Value6.025 Billion
Total Cash577.318 Million Current Debt167.188 Million Gross Profit89.123 Million
BETA1.05091 52-week High/Low93.66 / 32.86 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -320.5029
Data provided by IEX Cloud
View SEC Filings from ARWR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 5 -20.0% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 286 309 -7.44% 72 (4.23%) 71 (4.12%) 1.41%
13F shares: 67.729 Million 69.401 Million -2.41% 11.845 Million 12.726 Million -6.92%
% Ownership 65.2545 67.5396 -3.38% 11.4123 12.3842 -7.85%
New Positions: 31 73 -57.53% 12 18 -33.33%
Increased Positions 83 90 -7.78% 16 17 -5.88%
Closed Positions 49 25 96.0% 8 14 -42.86%
Reduced Positions 124 110 12.73% 34 33 3.03%
Total Calls 889.962 Thousand 1.62 Million -45.08% 167.4 Thousand 439.8 Thousand -61.94%
Total Puts 394.119 Thousand 782.778 Thousand -49.65% 120.41 Thousand 363.91 Thousand -66.91%
PUT/CALL Ratio 0.44 0.48 -8.33% 0.72 0.83 -13.25%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARWR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARWR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

13.1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DE BACKER MARIANNE

  • Director
21,500 2021-06-24 3

GIVEN DOUGLAS B

  • Director
141,243 2021-06-22 6

HASSARD JAMES CHIEF COMMERCIAL OFFICER

  • Officer
105,750 2021-06-22 2

O'BRIEN PATRICK GENERAL COUNSEL

  • Officer
293,375 2021-02-08 3

HAMILTON JAMES C

  • SENIOR VICE PRESIDENT
126,250 2021-01-14 4

MYSZKOWSKI KENNETH ALLEN CHIEF FINANCIAL OFFICER

  • Officer
444,005 2021-01-11 5

PERRY MICHAEL S

  • Director
90,000 2021-01-01 1

FERRARI MAURO

  • Director
39,971 2021-01-01 2

WADDILL WILLIAM D.

  • Director
30,250 2021-01-01 2

OLUKOTUN ADEOYE Y

  • Director
14,000 2021-01-01 2

ANZALONE CHRISTOPHER RICHARD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
3,344,022 2020-12-30 6

BRADSHAW CURT CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2020-11-19 1

SAN MARTIN JAVIER CHIEF MEDICAL OFFICER

  • Officer
130,500 2020-11-19 1

GIVEN BRUCE D CHIEF OPERATING OFFICER

  • Officer
850,730 2020-04-27 0

LI ZHEN SNR. VP, CHEM AND NON-CLIN DEV

  • Officer
201,700 2019-01-14 0

LEONE PETER BRIAN VP, STRATEGIC BUS. INITIATIVES

  • Officer
130,000 2018-10-19 0

FRYKMAN EDWARD W

  • Director
148,852 2018-01-01 0

LEWIS DAVID L. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-01-01 0

MCKENNEY CHARLES

  • Director
42,220 2015-03-04 0

RAHN LEROY T

  • Director
0 2010-03-04 0

STEWART R BRUCE EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2010-03-04 0

MCDONNEL PAUL CLAYTON CFO (FORMER)

  • Officer
No longer subject to file 2009-07-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DE BACKER MARIANNE - Director

2021-06-25 18:59:04 -0400 2021-06-24 S 5,000 $89.85 d 21,500 direct -5.4744 -26.8499 0.0 1 -26.8499 6

GIVEN DOUGLAS B - Director

2021-06-24 16:47:24 -0400 2021-06-22 S 4,500 $89.21 d 114,868 direct -4.5394 -30.1041 0.0 1 -30.1041 6

HASSARD JAMES - Officer CHIEF COMMERCIAL OFFICER

2021-06-24 18:44:06 -0400 2021-06-22 S 3,625 $89.22 d 105,750 direct -4.5394 -30.1041 0.0 1 -30.1041 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 16:15:02 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 15:45:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 15:15:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 14:45:02 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 14:15:03 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 13:45:02 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 13:15:03 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-28 12:45:03 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 22:15:03 UTC -0.1758 0.2558 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 21:45:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 21:15:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 20:45:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 20:15:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 19:45:02 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 19:15:02 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 18:45:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 18:15:02 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 17:45:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 17:15:03 UTC -0.17 0.25 1600000
ARROWHEAD PHARMACEUTICALS IN ARWR 2021-07-27 16:45:02 UTC -0.17 0.25 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Market Neutral Fund ARWR -1493.0 shares, $-63064.32 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund ARWR -124.0 shares, $-5339.44 2020-09-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund ARWR -585.0 shares, $-45144.45 2021-01-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund ARWR -397.0 shares, $-26325.07 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund ARWR -6952.0 shares, $-460987.12 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund ARWR -2196.0 shares, $-145616.76 2021-03-31 N-PORT
AQR Funds- AQR Multi-Asset Fund ARWR -1762.0 shares, $-116838.22 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund ARWR -15391.0 shares, $-1020577.21 2021-03-31 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND ARWR -12747.0 shares, $-845253.57 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund ARWR -1361.0 shares, $-99026.36 2021-04-30 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund ARWR -1302.0 shares, $-94733.52 2021-04-30 N-PORT

Elevate your investments